Published by Xtrava Health on March 10, 2021

Xtrava Health has been awarded a contract by the National Institutes of Health (in collaboration with the Biomedical Advanced Research and Development Authority) under the Rapid Acceleration of Diagnostics Tech (RADx Tech) fast track program, which supports the development and commercialization of innovative technologies to significantly increase the U.S. testing capacity for SARS-CoV-2, the virus that causes COVID-19. 

Read the NIH press release for additional information.